Latanoprost/Timolol Biogaran

Latanoprost and Timolol, the active ingredients in Latanoprost/Timolol Biogaran, are a prostaglandin analog and a beta‑blocker presented as eye drops for ocular (topical) use. They treat open‑angle glaucoma and ocular hypertension in adults.

GNH USA supplies Latanoprost/Timolol Biogaran as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost/Timolol is a combination antiglaucoma therapy that reduces intraocular pressure by affecting aqueous humor dynamics.

Open-angle glaucoma: lowers intraocular pressure to prevent optic nerve damage. Ocular hypertension: reduces elevated eye pressure to lower the risk of developing glaucoma.

Common Side Effects: - Eye irritation or burning sensation. - Blurred vision shortly after instillation. - Increased pigmentation of the iris or eyelash growth. - Conjunctival hyperemia (red eye). - Mild ocular discomfort.

Serious or Rare Side Effects: - Severe allergic reaction (e.g., angio‑edema, urticaria). - Bronchospasm or worsening asthma. - Marked bradycardia or hypotension. - Corneal edema or keratitis. - Systemic beta‑blocker effects such as fatigue or dizziness.

Before initiating therapy, consider the following precautions: - Cardiac history: avoid in patients with severe bradycardia or heart block. - Respiratory status: use cautiously in asthma or COPD. - Hypersensitivity: discontinue if allergic eye reaction occurs. - Concomitant beta‑blockers: avoid using additional systemic or ocular beta‑blockers. - Pregnancy and lactation: prescribe only if benefit outweighs potential risk. - Store at room temperature: keep in the original container, protect from light and moisture.

Latanoprost/Timolol may interact with other medicines as follows:

Major Interactions (Avoid): - Systemic non‑selective beta‑blockers: additive bradycardia or hypotension. - Calcium channel blockers: increased risk of cardiac conduction effects. - Other prostaglandin analog eye drops: heightened ocular irritation.

Moderate Interactions (Monitor Closely): - Anticholinergic ophthalmic agents: may affect pupil size and intraocular pressure. - Systemic antihypertensives: monitor blood pressure for additive lowering. - Inhaled beta‑agonists: possible reduction of bronchodilator efficacy.